(Q34386138)

1 August 2017

title

MELD accurately predicts mortality in patients with alcoholic hepatitis (English)

1 reference

1 August 2017

0 references

Winston Dunn

1

1 reference

1 August 2017

Laith H Jamil

2

1 reference

1 August 2017

Larry S Brown

3

1 reference

1 August 2017

Russell H Wiesner

4

1 reference

1 August 2017

W Ray Kim

5

1 reference

1 August 2017

K V Narayanan Menon

6

1 reference

1 August 2017

Michael Malinchoc

7

1 reference

1 August 2017

Patrick S Kamath

8

1 reference

1 August 2017

Vijay Shah

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

1 August 2017

1 reference

1 August 2017

volume

41

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

353-358

1 reference

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials

1 August 2017

cites work

1 reference

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

21 January 2018

1 reference

The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis

21 January 2018

1 reference

Pathogenesis, diagnosis, and treatment of alcoholic liver disease

21 January 2018

1 reference

7 January 2021

Treatment of alcoholic hepatitis

1 reference

7 January 2021

Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology

1 reference

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

7 January 2021

Pentoxifylline and alcoholic hepatitis

1 reference

7 January 2021

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

1 reference

7 January 2021

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

1 reference

7 January 2021

Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity

1 reference

7 January 2021

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

7 January 2021

A model to predict survival in patients with end-stage liver disease

1 reference

7 January 2021

MELD and PELD: application of survival models to liver allocation

1 reference

7 January 2021

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

7 January 2021

A randomized trial of prednisolone in patients with severe alcoholic hepatitis

1 reference

7 January 2021

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

7 January 2021

A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis

1 reference

7 January 2021

Is the change in MELD score a better indicator of mortality than baseline MELD score?

1 reference

7 January 2021

Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis

1 reference

7 January 2021

Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease

1 reference

7 January 2021

The rational clinical examination. Does this patient have ascites? How to divine fluid in the abdomen

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20503

1 reference

1 August 2017

1 reference